Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial

Fig. 3

Posterior distribution of A days alive and free of KRT and B days alive and free of hospitalization. The vertical dashed line represents no difference; values favoring accelerated strategy are shown in blue and probability mass suggesting harm is filled in red. The vertical gray lines at − 3 and + 3 mark what was considered a MCID by the steering committee

Back to article page

Critical Care

ISSN: 1364-8535